Presence of BRAF V600E in very early stages of papillary thyroid carcinoma

Clara Ugolini, Riccardo Giannini, Cristiana Lupi, Giuliana Salvatore, Paolo Miccoli, Agnese Proietti, Rossella Elisei, Massimo Santoro, Fulvio Basolo

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Objective: Extremely small (often 0.54 mm) incidental thyroid malignancies (incidental microcarcinomas, IM) might be discovered at histological examination after surgery in patients who were operated on for benign thyroid conditions. Morphologically, these malignancies have virtually always features of differentiated papillary thyroid carcinoma (PTC). Although IM are in general considered of little clinical significance their potential malignant behavior cannot be ignored. BRAF(V600E) mutation has emerged as the most prevalent genetic alteration in PTC. Design: The incidence of BRAF(V600E) was studied in 85 microdissected cases of IM detected in two series of 334 and 398 patients operated on for benign thyroid disease in 2005 and in 2006, respectively. IM ranged in size from 0.5 to 4 mm and all featured cytology consistent with the diagnosis of PTC. Microdissected lesions were also evaluated for galectin-3 expression by immunohistochemistry. Main outcome: BRAF(V600E) was identified in 15 out of 85 (17.6%) IM compared to 45% clinically evident PTCs (n = 91) and 38.3% preoperatively identified microcarcinomas (n = 47). Conclusion: These data suggest that it is possible to find BRAF(V600E) in IM despite their extremely small (

Original languageEnglish
Pages (from-to)381-388
Number of pages8
JournalThyroid
Volume17
Issue number5
DOIs
Publication statusPublished - May 2007

Fingerprint

Thyroid Gland
Galectin 3
Factor IX
Thyroid Diseases
Cell Biology
Neoplasms
Immunohistochemistry
Mutation
Incidence
Papillary Thyroid cancer

ASJC Scopus subject areas

  • Endocrinology

Cite this

Ugolini, C., Giannini, R., Lupi, C., Salvatore, G., Miccoli, P., Proietti, A., ... Basolo, F. (2007). Presence of BRAF V600E in very early stages of papillary thyroid carcinoma. Thyroid, 17(5), 381-388. https://doi.org/10.1089/thy.2006.0305

Presence of BRAF V600E in very early stages of papillary thyroid carcinoma. / Ugolini, Clara; Giannini, Riccardo; Lupi, Cristiana; Salvatore, Giuliana; Miccoli, Paolo; Proietti, Agnese; Elisei, Rossella; Santoro, Massimo; Basolo, Fulvio.

In: Thyroid, Vol. 17, No. 5, 05.2007, p. 381-388.

Research output: Contribution to journalArticle

Ugolini, C, Giannini, R, Lupi, C, Salvatore, G, Miccoli, P, Proietti, A, Elisei, R, Santoro, M & Basolo, F 2007, 'Presence of BRAF V600E in very early stages of papillary thyroid carcinoma', Thyroid, vol. 17, no. 5, pp. 381-388. https://doi.org/10.1089/thy.2006.0305
Ugolini C, Giannini R, Lupi C, Salvatore G, Miccoli P, Proietti A et al. Presence of BRAF V600E in very early stages of papillary thyroid carcinoma. Thyroid. 2007 May;17(5):381-388. https://doi.org/10.1089/thy.2006.0305
Ugolini, Clara ; Giannini, Riccardo ; Lupi, Cristiana ; Salvatore, Giuliana ; Miccoli, Paolo ; Proietti, Agnese ; Elisei, Rossella ; Santoro, Massimo ; Basolo, Fulvio. / Presence of BRAF V600E in very early stages of papillary thyroid carcinoma. In: Thyroid. 2007 ; Vol. 17, No. 5. pp. 381-388.
@article{97844b9ea6a24c62ae2738135da25558,
title = "Presence of BRAF V600E in very early stages of papillary thyroid carcinoma",
abstract = "Objective: Extremely small (often 0.54 mm) incidental thyroid malignancies (incidental microcarcinomas, IM) might be discovered at histological examination after surgery in patients who were operated on for benign thyroid conditions. Morphologically, these malignancies have virtually always features of differentiated papillary thyroid carcinoma (PTC). Although IM are in general considered of little clinical significance their potential malignant behavior cannot be ignored. BRAF(V600E) mutation has emerged as the most prevalent genetic alteration in PTC. Design: The incidence of BRAF(V600E) was studied in 85 microdissected cases of IM detected in two series of 334 and 398 patients operated on for benign thyroid disease in 2005 and in 2006, respectively. IM ranged in size from 0.5 to 4 mm and all featured cytology consistent with the diagnosis of PTC. Microdissected lesions were also evaluated for galectin-3 expression by immunohistochemistry. Main outcome: BRAF(V600E) was identified in 15 out of 85 (17.6{\%}) IM compared to 45{\%} clinically evident PTCs (n = 91) and 38.3{\%} preoperatively identified microcarcinomas (n = 47). Conclusion: These data suggest that it is possible to find BRAF(V600E) in IM despite their extremely small (",
author = "Clara Ugolini and Riccardo Giannini and Cristiana Lupi and Giuliana Salvatore and Paolo Miccoli and Agnese Proietti and Rossella Elisei and Massimo Santoro and Fulvio Basolo",
year = "2007",
month = "5",
doi = "10.1089/thy.2006.0305",
language = "English",
volume = "17",
pages = "381--388",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Presence of BRAF V600E in very early stages of papillary thyroid carcinoma

AU - Ugolini, Clara

AU - Giannini, Riccardo

AU - Lupi, Cristiana

AU - Salvatore, Giuliana

AU - Miccoli, Paolo

AU - Proietti, Agnese

AU - Elisei, Rossella

AU - Santoro, Massimo

AU - Basolo, Fulvio

PY - 2007/5

Y1 - 2007/5

N2 - Objective: Extremely small (often 0.54 mm) incidental thyroid malignancies (incidental microcarcinomas, IM) might be discovered at histological examination after surgery in patients who were operated on for benign thyroid conditions. Morphologically, these malignancies have virtually always features of differentiated papillary thyroid carcinoma (PTC). Although IM are in general considered of little clinical significance their potential malignant behavior cannot be ignored. BRAF(V600E) mutation has emerged as the most prevalent genetic alteration in PTC. Design: The incidence of BRAF(V600E) was studied in 85 microdissected cases of IM detected in two series of 334 and 398 patients operated on for benign thyroid disease in 2005 and in 2006, respectively. IM ranged in size from 0.5 to 4 mm and all featured cytology consistent with the diagnosis of PTC. Microdissected lesions were also evaluated for galectin-3 expression by immunohistochemistry. Main outcome: BRAF(V600E) was identified in 15 out of 85 (17.6%) IM compared to 45% clinically evident PTCs (n = 91) and 38.3% preoperatively identified microcarcinomas (n = 47). Conclusion: These data suggest that it is possible to find BRAF(V600E) in IM despite their extremely small (

AB - Objective: Extremely small (often 0.54 mm) incidental thyroid malignancies (incidental microcarcinomas, IM) might be discovered at histological examination after surgery in patients who were operated on for benign thyroid conditions. Morphologically, these malignancies have virtually always features of differentiated papillary thyroid carcinoma (PTC). Although IM are in general considered of little clinical significance their potential malignant behavior cannot be ignored. BRAF(V600E) mutation has emerged as the most prevalent genetic alteration in PTC. Design: The incidence of BRAF(V600E) was studied in 85 microdissected cases of IM detected in two series of 334 and 398 patients operated on for benign thyroid disease in 2005 and in 2006, respectively. IM ranged in size from 0.5 to 4 mm and all featured cytology consistent with the diagnosis of PTC. Microdissected lesions were also evaluated for galectin-3 expression by immunohistochemistry. Main outcome: BRAF(V600E) was identified in 15 out of 85 (17.6%) IM compared to 45% clinically evident PTCs (n = 91) and 38.3% preoperatively identified microcarcinomas (n = 47). Conclusion: These data suggest that it is possible to find BRAF(V600E) in IM despite their extremely small (

UR - http://www.scopus.com/inward/record.url?scp=34249940475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249940475&partnerID=8YFLogxK

U2 - 10.1089/thy.2006.0305

DO - 10.1089/thy.2006.0305

M3 - Article

VL - 17

SP - 381

EP - 388

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 5

ER -